PubRank

Comparison of Cervical Cancer Screening Tests in HIV-infected Women in Lusaka, Zambia

Clinical Trial ID NCT02688816

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02688816

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010 90.16
2 Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995 18.86
3 HPV screening for cervical cancer in rural India. N Engl J Med 2009 14.13
4 The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006 13.57
5 Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007 11.06
6 Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999 3.37
7 Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS 2009 2.42
8 Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med 2011 2.28
9 How will HPV vaccines affect cervical cancer? Nat Rev Cancer 2006 2.23
10 Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method. J Natl Cancer Inst 2012 1.86
11 Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One 2013 1.37
12 Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev Anti Infect Ther 2010 1.27
13 Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000 1.20
14 Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma. Am J Surg Pathol 1999 1.14
15 The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis 1994 1.11
16 Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 2003 1.10
17 Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India. PLoS One 2010 1.09
18 A review of methods for detect human Papillomavirus infection. Virol J 2012 1.09
19 Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev 2010 1.08
20 Visual inspection of the cervix with acetic acid for cervical intraepithelial lesions. Int J Gynaecol Obstet 2005 1.02
21 A population-based five-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol 2000 0.98
22 Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer. J Clin Microbiol 2010 0.96
23 A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities. Acta Obstet Gynecol Scand 2005 0.87
24 Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control. J Cancer Epidemiol 2011 0.80
Next 100